On October 2, 2019, Adicet Bio, Inc. closed the transaction. The transaction included participation from 18 investors including new investors aMoon Fund., DSC Investment Inc. (KOSDAQ:A241520), Handok, Inc. (KOSE:A002390), Johnson & Johnson Innovation - JJDC, Inc., KB Investment Co., Ltd., OCI Enterprises, Inc., Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN), Samsung Venture Investment Corporation, SBI JI Innovation Advisory Ltd., and Vincos Limited, and existing investors including Novartis Venture Funds, OrbiMed Advisors, L.L.C., Pontifax Ltd. Representative from Johnson & Johnson Innovation - JJDC, Inc. and Yair Schindel from aMoon Fund will join company's board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,655 KRW | +0.55% | +0.83% | +16.40% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,590 KRW | -0.95% | +1.57% | 138M | ||
957 USD | +2.07% | +8.36% | 105B | ||
1.45 USD | +2.84% | -13.69% | 119M | ||
1st Jan change | Capi. | |
---|---|---|
+16.40% | 71.44M | |
+16.56% | 3.11B | |
+31.41% | 2.06B | |
+4.05% | 1.45B | |
-8.46% | 1.23B | |
+2.85% | 673M | |
+2.39% | 624M | |
+35.03% | 576M | |
-1.12% | 511M | |
+25.93% | 466M |
- Stock Market
- Equities
- A241520 Stock
- News DSC Investment Inc.
- Adicet Bio, Inc. announced that it has received $80 million in funding from a group of investors